Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Revenue
Forecast
Revenue Estimate
Wuhan Easy Diagnosis Biomedicine Co Ltd
For the last 8 years the
compound annual growth rate for
Wuhan Easy Diagnosis Biomedicine Co Ltd's revenue is
92%.
The projected
CAGR
for the next 2 years is
-46%.
Net Income
Forecast
Net Income Estimate
Wuhan Easy Diagnosis Biomedicine Co Ltd
For the last 8 years the
compound annual growth rate for
Wuhan Easy Diagnosis Biomedicine Co Ltd's net income is
93%.
The projected
CAGR
for the next 2 years is
-28%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's stock price target?
Not Available
Wuhan Easy Diagnosis Biomedicine Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Revenue forecast?
Projected CAGR
-46%
For the last 8 years the
compound annual growth rate for
Wuhan Easy Diagnosis Biomedicine Co Ltd's revenue is
92%.
The projected
CAGR
for the next 2 years is
-46%.
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Net Income forecast?
Projected CAGR
-28%
For the last 8 years the
compound annual growth rate for
Wuhan Easy Diagnosis Biomedicine Co Ltd's net income is
93%.
The projected
CAGR
for the next 2 years is
-28%.
You don't have any saved screeners yet
